Study aims to simplify Post-Surgery eye care for diabetics
NCT ID NCT04977427
Summary
This study aimed to compare two different eye drop treatments for controlling inflammation after cataract surgery in patients with diabetes. It planned to test if a single, long-acting insert (Dextenza) was as effective as a four-week schedule of standard steroid eye drops (prednisolone). The goal was to find a more convenient option that patients might find easier to use correctly, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT DIABETIC are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.